VBContract PerformanceClaims through 2026-09-30 · CY2026
Portfolio
ACO REACH

ACO REACH – Global

Meeting financial and quality targets

On track
Attributed lives
8,420
Spend vs benchmark
-6.2%
$1112 vs $1185 PMPM
Quality score
82
Gate 75
Projected settlement
$7.4M
Downside exposure $119.7M

Contract terms

Payer
CMS
Arrangement
Global (100% risk)
Risk
Two-sided
Period
CY2026
Benchmark
$1185 PMPM
Shared savings
100%
Shared loss
100%
MSR
0%
Quality gate
75

Data completeness

91%

Claims through 2026-09-30. Recent months completed with IBNR estimates.

PMPM spend vs benchmark

Dashed = IBNR-estimated months

Quality measures

Marker = target
Controlling High BP
69% / 70%
19 gaps
Diabetes HbA1c <9
75% / 75%
Met
Breast Cancer Screening
74% / 74%
Met
Colorectal Screening
67% / 68%
16 gaps
Med Adherence – Statins
89% / 88%
Met

Utilization

Admits / 1000
242
ED / 1000
610
Readmit %
15.2
SNF days / 1000
1180

Risk adjustment

1.18

▲ 0.04 vs prior year (1.14)

RAF drives benchmark / premium — falling RAF shrinks revenue.